FDA Issues First Action Plan for Overseeing Medical AI Software
- January 15, 2021
The Food and Drug Administration (FDA) released January 12 its first action plan for furthering oversight of artificial intelligence/machine-learning based software as a medical device.
ARTICLE TAGS
You must be logged in to access this content.